Study to Evaluate the Effect of Intravenous (IV) Paricalcitol (Zemplar) on Cardiac Morbidity in Patients With Chronic Kidney Disease (CKD) Stage 5 Over 2 Years

NCT01073462 · clinicaltrials.gov ↗

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Secondary Hyperparathyroidism
Chronic Kidney Disease Stage V
Cardiac Morbidity

Sponsor

AbbVie (prior sponsor, Abbott)

Collaborators

[object Object]